Article

Tongji completes Langdong Hospital with help from German consultant

To complete its Langdong Hospital in Nanning, China, Tongji Healthcare, Inc. has engaged German-based Dr. Petri Hospital Consulting.

New York-To complete its Langdong Hospital in Nanning, China, Tongji Healthcare, Inc. has engaged German-based Dr. Petri Hospital Consulting.

The health-care and pharmaceutical services provider previously announced the hospital was nearly complete, but has now re-adjusted architectural and operational plans to include additional features.

The new project will incorporate additional architecture to connect with the original buildings, an additional parking tower, and 200 more sick beds. State-of-the-art facilities will be offered for neuro-ophthalmology surgery, ophthalmic plastic surgery, retinal disease, and diabetic retinopathy, as well as pediatric ophthalmology.

"Due to the recent disaster in the Sichuan province, we felt that adding space and features to the hospital made sense for long-term health care in our Province. We have held discussions with numerous western architectural firms to re-engineer our project and feel we have chosen the 'best one'," said Yun-hui Yu, president and chief executive officer. "We know we are a bit behind schedule, but unforeseen events have made it apparent that to satisfy the increased demand in patients, we needed to add important features to improve the health-care facilities."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.